BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Kidney tumors AND VHL, HRCA1, P40337, 7428, ENSG00000134086, RCA1, VHL1 AND Diagnosis
172 results:

  • 1. [Activation of HIF-1α/ACLY signaling axis promotes progression of clear cell renal cell carcinoma with vhl inactivation mutation].
    Ma Y; Wang YH; Huang S; Zou ZG; Hu L; Guo LC
    Zhonghua Bing Li Xue Za Zhi; 2023 Dec; 52(12):1230-1236. PubMed ID: 38058039
    [No Abstract]    [Full Text] [Related]  

  • 2. Update of the UMD-vhl database: classification of 164 challenging variants based on genotype-phenotype correlation among 605 entries.
    Mougel G; Mohamed A; Burnichon N; Giraud S; Pigny P; Bressac-de Paillerets B; Mirebeau-Prunier D; Buffet A; Savagner F; Romanet P; Arlot Y; Gardie B; Gimenez-Roqueplo AP; Beroud C; Richard S; Barlier A
    J Med Genet; 2024 Mar; 61(4):378-384. PubMed ID: 37979962
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. A Rare Presentation of Aggressive Renal Cell Carcinoma and the Utility of Early Molecular Testing in Rapidly Progressing Malignancies: A Case Report.
    McLoughlin DE; Chevalier N; Choy E; Cote GM; Gao X; Juric D; Reynolds KL
    Oncologist; 2023 Dec; 28(12):1094-1099. PubMed ID: 37844295
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Hemangioblastomas and Other Vascular Origating tumors of Brain or Spinal Cord.
    Vetrano IG; Gioppo A; Faragò G; Pinzi V; Pollo B; Broggi M; Schiariti M; Ferroli P; Acerbi F
    Adv Exp Med Biol; 2023; 1405():377-403. PubMed ID: 37452946
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Two tests of peripheral blood by standard methods were negative for Von Hippel-Lindau mutations: A case report.
    Deng B; Liu C
    Asian J Surg; 2023 Sep; 46(9):4101-4102. PubMed ID: 37147258
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. [Pathological characteristics and genetic background of renal cell carcinoma].
    Sánta F; Pósfai B; Sejben A; Kuthi L
    Magy Onkol; 2023 Apr; 67(1):7-17. PubMed ID: 37086452
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Synchronous or metachronous presentation of pancreatic neuroendocrine tumor versus secondary lesion to pancreas in patients affected by renal cell carcinoma. Systematic review.
    Persano I; Parlagreco E; La Salvia A; Audisio M; Volante M; Buttigliero C; Scagliotti GV; Brizzi MP
    Semin Oncol; 2022 Dec; 49(6):476-481. PubMed ID: 36759234
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Epidemiology and Economic Burden of von Hippel-Lindau Disease-Associated Renal Cell Carcinoma in the United States.
    Jonasch E; Song Y; Freimark J; Berman R; Nguyen H; Signorovitch J; Sundaram M
    Clin Genitourin Cancer; 2023 Apr; 21(2):238-247. PubMed ID: 36682891
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Comprehensive characterization and building of National Registry of von Hippel-Lindau disease in Brazil.
    Dallagnol TN; Da Cás E; Junior OR; Casali-da-Rocha JC
    Mol Genet Genomic Med; 2023 Apr; 11(4):e2136. PubMed ID: 36625343
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. New insights in the new WHO classification of adult renal tumors.
    Hes O; Michalová K; Pivovarčíková K
    Cesk Patol; 2022; 67(4):187-191. PubMed ID: 36513503
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Deciphering intratumor heterogeneity in clear cell renal cell carcinoma utilizing clinicopathologic and molecular platforms.
    Vormittag-Nocito E; Mannan R; Wang X; Chinnaiyan A; Zhang Y; Zelenka-Wang S; Cao X; Morgan TM; Hafez K; Vaishampayan U; Abdulfatah E; Chinnaiyan AM; Dhanasekaran SM; Mehra R
    Hum Pathol; 2022 Dec; 130():95-109. PubMed ID: 36511267
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Renal cell carcinoma, synchronous pheochromocytoma and papillary urothelial neoplasm with low Malignant Potential.
    D Arican C; Sancaktep SIV; Bayar G
    Ann Ital Chir; 2022 Oct; 11():. PubMed ID: 36259433
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Renal cell carcinoma: an overview of the epidemiology, diagnosis, and treatment.
    Bahadoram S; Davoodi M; Hassanzadeh S; Bahadoram M; Barahman M; Mafakher L
    G Ital Nefrol; 2022 Jun; 39(3):. PubMed ID: 35819037
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. von Hippel-Lindau disease: Updated guideline for diagnosis and surveillance.
    Louise M Binderup M; Smerdel M; Borgwadt L; Beck Nielsen SS; Madsen MG; Møller HU; Kiilgaard JF; Friis-Hansen L; Harbud V; Cortnum S; Owen H; Gimsing S; Friis Juhl HA; Munthe S; Geilswijk M; Rasmussen ÅK; Møldrup U; Graumann O; Donskov F; Grønbæk H; Stausbøl-Grøn B; Schaffalitzky de Muckadell O; Knigge U; Dam G; Wadt KA; Bøgeskov L; Bagi P; Lund L; Stochholm K; Ousager LB; Sunde L
    Eur J Med Genet; 2022 Aug; 65(8):104538. PubMed ID: 35709961
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Differential vhl Mutation Patterns in Bilateral Clear Cell RCC Distinguishes Between Independent Primary tumors and Contralateral Metastatic Disease.
    Vocke CD; Ricketts CJ; Metwalli AR; Pinto PA; Gautam R; Raffeld M; Merino MJ; Ball MW; Linehan WM
    Urology; 2022 Jul; 165():170-177. PubMed ID: 35469800
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Primary hemangioblastoma of the kidney with molecular analyses by next generation sequencing: a case report and review of the literature.
    Wang X; Haines GK; Mehrotra M; Houldsworth J; Si Q
    Diagn Pathol; 2022 Feb; 17(1):34. PubMed ID: 35220972
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Clear cell and papillary renal cell carcinomas in hereditary papillary renal cell carcinoma (HPRCC) syndrome: a case report.
    Ferlicot S; Just PA; Compérat E; Rouleau E; Tissier F; Vaessen C; Richard S
    Diagn Pathol; 2021 Nov; 16(1):107. PubMed ID: 34801057
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Von Hippel-Lindau disease-associated renal cell carcinoma: a call to action.
    Larcher A; Rowe I; Belladelli F; Fallara G; Raggi D; Necchi A; Montorsi F; Capitanio U; Salonia A;
    Curr Opin Urol; 2022 Jan; 32(1):31-39. PubMed ID: 34783716
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Assessment of Risk of Hereditary Predisposition in Patients With Melanoma and/or Mesothelioma and Renal Neoplasia.
    Gupta S; Erickson LA; Lohse CM; Shen W; Pitel BA; Knight SM; Halling KC; Herrera-Hernandez L; Boorjian SA; Thompson RH; Leibovich BC; Jimenez RE; Cheville JC
    JAMA Netw Open; 2021 Nov; 4(11):e2132615. PubMed ID: 34767027
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Genetic profile and immunohistochemical study of clear cell renal carcinoma: Pathological-anatomical correlation and prognosis.
    Diez-Calzadilla NA; Noguera Salvá R; Soriano Sarrió P; Martínez-Jabaloyas JM
    Cancer Treat Res Commun; 2021; 27():100374. PubMed ID: 33932757
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 9.